LC-MS for RNA Therapeutics to Ensure Product Quality and Process Consistency
41:21
Description
Related Videos
LC-MS for RNA Therapeutics to Ensure Product Quality and Process Consistency
View More
View Less
41:21
LC-MS for RNA Therapeutics to Ensure Product Quality and Process Consistency
Critical to the development and commercialization of a biosimilar is understanding the originator and how its CQAs compare against those of the biosimilar. Learn more about our solutions that provide high quality peptide mapping, glycan and charge va
1:03:24
Join Waters Corporation for an insightful webinar on PFAS Analysis by EPA 1633 using LC-MS/MS. Learn essential techniques, best practices, and future advancements in PFAS testing to elevate your lab's capabilities.
44:12
Here we demonstrate how sample prep has been greatly simplified and automated to enable rapid LC-MS (intact and subunit) analysis at higher throughput, with less human intervention, all while providing high quality to support process development.
1:01:40
Clone selection, early in the development lifecycle, has an outsize impact on the ability to match the quality target product profile (QTPP) for a given product.
38:53
Released N-linked glycan analysis is the gold standard for N-glycan profiling of therapeutic monoclonal antibodies (mAbs) as they play an important role in safety and efficacy.
25:51
Discover the Xevo MRT MS: Performance and Speed Without Compromise. Join Prof. Perdita Barran from the University of Manchester as she discusses her Parkinson’s Disease research and insights from our development team on this incredible technology.
57:26